Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Postma

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 5, 2019
[Robot-assisted transaxillary thyroid surgery; 5 years later]Menno R Vriens, Emily L Postma, Inne H M Borel Rinkes
Virchows Archiv : an International Journal of Pathology|August 6, 2017
Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findingsMary-Ann El Sharouni, Emily L Postma, Paul J van Diest
World Journal of Surgery|October 12, 2012
Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases: replyEmily L Postma, Helena M Verkooijen, Maurice A A J van den Bosch, et al.
Expert Review of Anticancer Therapy|September 16, 2011
Localization of nonpalpable breast lesionsEmily L Postma, Arjen J Witkamp, Maurice Aaj van den Bosch, et al.
Breast Cancer Research and Treatment|September 12, 2025
Evaluating clinical response to primary endocrine therapy in elderly breast cancer patients in routine practiceTessa L Dinger, José H Volders, Anne Kuijer, et al.
BJS Open|September 26, 2023
Efficacy of indocyanine green fluorescence for the identification of non-palpable breast tumours: systematic reviewBritt A M Jansen, Claudia A Bargon, Anne E Huibers, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 23, 2011
MRI-guided ablation of breast cancer: where do we stand today?Emily L Postma, Richard van Hillegersberg, Bruce L Daniel, et al.
BMJ Open|June 24, 2026
Fluorescence imaging using indocyanine green to identify sentinel lymph nodes during surgery for breast cancer (INFINITE): protocol for a hybrid effectiveness-implementation trial using a stepped-wedge cluster designIsabelle J Henskens, Tessa L Dinger, Iza Stekelenburg, et al.
European Journal of Pharmacology|April 3, 2013
Discrepancy between routine and expert pathologists' assessment of non-palpable breast cancer and its impact on locoregional and systemic treatmentEmily L Postma, Helena M Verkooijen, Paul J van Diest, et al.
Breast (Edinburgh, Scotland)|December 3, 2025
Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelinesEline E F Verreck, Emily L Postma, Tanja Oostergo, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|April 5, 2019
[Robot-assisted transaxillary thyroid surgery; 5 years later]Menno R Vriens, Emily L Postma, Inne H M Borel Rinkes
Virchows Archiv : an International Journal of Pathology|August 6, 2017
Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findingsMary-Ann El Sharouni, Emily L Postma, Paul J van Diest
World Journal of Surgery|October 12, 2012
Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases: replyEmily L Postma, Helena M Verkooijen, Maurice A A J van den Bosch, et al.
Expert Review of Anticancer Therapy|September 16, 2011
Localization of nonpalpable breast lesionsEmily L Postma, Arjen J Witkamp, Maurice Aaj van den Bosch, et al.
Breast Cancer Research and Treatment|September 12, 2025
Evaluating clinical response to primary endocrine therapy in elderly breast cancer patients in routine practiceTessa L Dinger, José H Volders, Anne Kuijer, et al.
BJS Open|September 26, 2023
Efficacy of indocyanine green fluorescence for the identification of non-palpable breast tumours: systematic reviewBritt A M Jansen, Claudia A Bargon, Anne E Huibers, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 23, 2011
MRI-guided ablation of breast cancer: where do we stand today?Emily L Postma, Richard van Hillegersberg, Bruce L Daniel, et al.
BMJ Open|June 24, 2026
Fluorescence imaging using indocyanine green to identify sentinel lymph nodes during surgery for breast cancer (INFINITE): protocol for a hybrid effectiveness-implementation trial using a stepped-wedge cluster designIsabelle J Henskens, Tessa L Dinger, Iza Stekelenburg, et al.
European Journal of Pharmacology|April 3, 2013
Discrepancy between routine and expert pathologists' assessment of non-palpable breast cancer and its impact on locoregional and systemic treatmentEmily L Postma, Helena M Verkooijen, Paul J van Diest, et al.
Breast (Edinburgh, Scotland)|December 3, 2025
Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelinesEline E F Verreck, Emily L Postma, Tanja Oostergo, et al.
Pageof 3